Latest Transformation News

Hastings Technology Metals has completed a transformative joint venture with Wyloo for its Yangibana Rare Earths Project, eliminating $123 million in debt and divesting its gold portfolio to sharpen its rare earths focus.

CAR Group Limited has reported robust FY25 financial results with strong revenue and profit growth, underpinned by strategic investments in AI and digital marketplaces. The company projects continued momentum into FY26, aiming to deepen market leadership across global regions.

TrivarX has reported promising interim results from its US veteran-focused mental health trial using ECG technology, while progressing a strategic acquisition of novel brain tumor imaging IP to broaden its diagnostic portfolio.

Mammoth Minerals has completed key US gold project acquisitions and launched exploration drilling, backed by a $5 million capital raise and strategic board appointments.

Catapult Sports has completed its acquisition of IMPECT GmbH, a leader in soccer scouting analytics, enhancing its technology suite with proprietary data insights.

First Au Limited accelerates exploration at its Gimlet and Nimba gold projects through innovative drill-for-equity agreements and diamond drilling, while progressing a strategic divestment of its Victorian assets.

Flagship Minerals has secured a valuable historical dataset from Anglo, significantly advancing its Pantanillo Gold Project towards feasibility and construction, supported by a strategic EPC partnership and a recent $4 million capital raise.

Cluey Ltd reported a stable Q1 FY26 revenue of $7.4 million alongside its strongest-ever underlying EBITDA, as it accelerates investment in AI-driven educational products set to launch in 2026.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.

Resmed Inc. kicked off fiscal 2026 with robust 9% revenue growth and a notable 290 basis points gross margin expansion, signaling strong momentum in home healthcare innovation. The company also declared a $0.60 dividend and executed a $150 million share buyback, underscoring confidence in its strategic direction.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

Aumake Limited reported a near-breakeven quarter with strong cash receipts and launched a new health product brand while securing a strategic partnership to expand Australian agricultural exports to China.